• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

平衡的 T 细胞和 B 细胞应答是病毒样颗粒疫苗接种预防波瓦桑病毒感染所必需的免疫保护。

Balanced T and B cell responses are required for immune protection against Powassan virus in virus-like particle vaccination.

机构信息

Department of Molecular Microbiology and Immunology, Saint Louis University, St. Louis, MO 63104, USA.

Center for Vector-borne Infectious Diseases, Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO 80523, USA.

出版信息

Cell Rep. 2022 Feb 15;38(7):110388. doi: 10.1016/j.celrep.2022.110388.

DOI:10.1016/j.celrep.2022.110388
PMID:35172138
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8919300/
Abstract

Powassan virus (POWV) is a tick-borne pathogen for which humans are an incidental host. POWV infection can be fatal or result in long-term neurological sequelae; however, there are no approved vaccinations for POWV. Integral to efficacious vaccine development is the identification of correlates of protection, which we accomplished in this study by utilizing a murine model of POWV infection. Using POWV lethal and sub-lethal challenge models, we show that (1) robust B and T cell responses are necessary for immune protection, (2) POWV lethality can be attributed to both viral- and host-mediated drivers of disease, and (3) knowledge of the immune correlates of protection against POWV can be applied in a virus-like particle (VLP)-based vaccination approach that provides protection from lethal POWV challenge. Identification of these immune protection factors is significant as it will aid in the rational design of POWV vaccines.

摘要

波瓦桑病毒(POWV)是一种蜱传病原体,人类是其偶然宿主。POWV 感染可能致命或导致长期神经后遗症;然而,目前尚无针对 POWV 的批准疫苗。有效的疫苗开发的关键是确定保护相关因素,我们在这项研究中通过利用 POWV 感染的小鼠模型来实现这一目标。使用 POWV 致死性和亚致死性挑战模型,我们表明:(1)强大的 B 和 T 细胞反应是免疫保护所必需的;(2)POWV 的致死性可归因于病毒和宿主介导的疾病驱动因素;(3)针对 POWV 的保护性免疫相关因素的知识可应用于基于病毒样颗粒(VLP)的疫苗接种方法,从而提供对致死性 POWV 挑战的保护。确定这些免疫保护因素非常重要,因为它将有助于合理设计 POWV 疫苗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8258/8919300/4e98689f7aa9/nihms-1781194-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8258/8919300/5d52512098fd/nihms-1781194-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8258/8919300/9134ccfa8281/nihms-1781194-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8258/8919300/1a7fd4318380/nihms-1781194-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8258/8919300/b6b90edc8a80/nihms-1781194-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8258/8919300/6eeb6b98798a/nihms-1781194-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8258/8919300/d0e075cc2e6c/nihms-1781194-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8258/8919300/4e98689f7aa9/nihms-1781194-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8258/8919300/5d52512098fd/nihms-1781194-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8258/8919300/9134ccfa8281/nihms-1781194-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8258/8919300/1a7fd4318380/nihms-1781194-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8258/8919300/b6b90edc8a80/nihms-1781194-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8258/8919300/6eeb6b98798a/nihms-1781194-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8258/8919300/d0e075cc2e6c/nihms-1781194-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8258/8919300/4e98689f7aa9/nihms-1781194-f0008.jpg

相似文献

1
Balanced T and B cell responses are required for immune protection against Powassan virus in virus-like particle vaccination.平衡的 T 细胞和 B 细胞应答是病毒样颗粒疫苗接种预防波瓦桑病毒感染所必需的免疫保护。
Cell Rep. 2022 Feb 15;38(7):110388. doi: 10.1016/j.celrep.2022.110388.
2
Age-dependent Powassan virus lethality is linked to glial cell activation and divergent neuroinflammatory cytokine responses in a murine model.年龄相关的波瓦桑病毒致死性与胶质细胞激活和在小鼠模型中的不同神经炎症细胞因子反应有关。
J Virol. 2024 Aug 20;98(8):e0056024. doi: 10.1128/jvi.00560-24. Epub 2024 Aug 1.
3
A novel synthetic DNA vaccine elicits protective immune responses against Powassan virus.一种新型合成 DNA 疫苗可引发针对波瓦桑病毒的保护性免疫应答。
PLoS Negl Trop Dis. 2020 Oct 29;14(10):e0008788. doi: 10.1371/journal.pntd.0008788. eCollection 2020 Oct.
4
Immune Cell Targets of Infection at the Tick-Skin Interface during Powassan Virus Transmission.波瓦桑病毒传播过程中蜱-皮肤界面感染的免疫细胞靶点
PLoS One. 2016 May 20;11(5):e0155889. doi: 10.1371/journal.pone.0155889. eCollection 2016.
5
Powassan Viruses Spread Cell to Cell during Direct Isolation from Ticks and Persistently Infect Human Brain Endothelial Cells and Pericytes.波瓦桑病毒在直接从蜱中分离时在细胞间传播,并持续感染人类脑内皮细胞和周细胞。
J Virol. 2022 Jan 12;96(1):e0168221. doi: 10.1128/JVI.01682-21. Epub 2021 Oct 13.
6
Broadly neutralizing monoclonal antibodies protect against multiple tick-borne flaviviruses.广泛中和性单克隆抗体可抵御多种蜱传黄病毒。
J Exp Med. 2021 May 3;218(5). doi: 10.1084/jem.20210174.
7
Tick Saliva Enhances Powassan Virus Transmission to the Host, Influencing Its Dissemination and the Course of Disease.蜱虫唾液增强波瓦桑病毒向宿主的传播,影响其扩散和病程。
J Virol. 2015 Aug;89(15):7852-60. doi: 10.1128/JVI.01056-15. Epub 2015 May 20.
8
Powassan Virus: An Emerging Arbovirus of Public Health Concern in North America.波瓦桑病毒:北美一种新出现的引起公共卫生关注的虫媒病毒。
Vector Borne Zoonotic Dis. 2017 Jul;17(7):453-462. doi: 10.1089/vbz.2017.2110. Epub 2017 May 12.
9
Serologic Evidence of Powassan Virus Infection in Patients with Suspected Lyme Disease.疑似莱姆病患者中波瓦桑病毒感染的血清学证据。
Emerg Infect Dis. 2017 Aug;23(8):1384-1388. doi: 10.3201/eid2308.161971.
10
Powassan virus encephalitis, Minnesota, USA.美国明尼苏达州波瓦桑病毒脑炎。
Emerg Infect Dis. 2012 Oct;18(10):1669-71. doi: 10.3201/eid1810.120621.

引用本文的文献

1
Innate Immune Response to Powassan Virus Infection: Progress Toward Infection Control.对波瓦桑病毒感染的先天免疫反应:感染控制方面的进展
Vaccines (Basel). 2025 Jul 15;13(7):754. doi: 10.3390/vaccines13070754.
2
The TLR7/8 agonist INI-4001 enhances the immunogenicity of a Powassan virus-like-particle vaccine.Toll样受体7/8激动剂INI-4001增强波瓦桑病毒样颗粒疫苗的免疫原性。
NPJ Vaccines. 2025 Jul 16;10(1):156. doi: 10.1038/s41541-025-01215-9.
3
Pathogenicity and virulence of Powassan virus.波瓦桑病毒的致病性和毒力

本文引用的文献

1
Prior Heterologous Flavivirus Exposure Results in Reduced Pathogenesis in a Mouse Model of Zika Virus Infection.既往黄病毒感染可降低寨卡病毒感染小鼠模型的发病机制。
J Virol. 2021 Jul 26;95(16):e0057321. doi: 10.1128/JVI.00573-21.
2
A Virus-Like Particle-Based Vaccine Candidate against the Tick-Borne Powassan Virus Induces Neutralizing Antibodies in a Mouse Model.一种基于病毒样颗粒的抗蜱传波瓦桑病毒候选疫苗在小鼠模型中诱导产生中和抗体。
Pathogens. 2021 May 31;10(6):680. doi: 10.3390/pathogens10060680.
3
Broadly neutralizing monoclonal antibodies protect against multiple tick-borne flaviviruses.
Virulence. 2025 Dec;16(1):2523887. doi: 10.1080/21505594.2025.2523887. Epub 2025 Jun 26.
4
Quantification of Neutralizing Antibodies of Tick-Borne Viruses Using Focus Neutralization Assays.使用蚀斑中和试验对蜱传病毒的中和抗体进行定量分析。
Methods Mol Biol. 2025;2936:117-124. doi: 10.1007/978-1-0716-4587-1_13.
5
Passage-attenuated Powassan virus LI9P protects mice from lethal LI9 challenge and links envelope residue D308 to neurovirulence.传代减毒的波瓦桑病毒LI9P可保护小鼠免受致死性LI9攻击,并将包膜残基D308与神经毒力联系起来。
mBio. 2025 Apr 9;16(4):e0006525. doi: 10.1128/mbio.00065-25. Epub 2025 Feb 25.
6
The TLR7/8 agonist INI-4001 enhances the immunogenicity of a Powassan virus-like-particle vaccine.Toll样受体7/8激动剂INI-4001增强波瓦桑病毒样颗粒疫苗的免疫原性。
bioRxiv. 2024 Dec 3:2024.11.28.625832. doi: 10.1101/2024.11.28.625832.
7
Immunoinformatics and computational approaches driven designing a novel vaccine candidate against Powassan virus.免疫信息学和计算方法驱动设计一种针对波瓦桑病毒的新型候选疫苗。
Sci Rep. 2024 Mar 12;14(1):5999. doi: 10.1038/s41598-024-56554-9.
8
Upsurge of Powassan virus disease in northeastern United States: a public health concern-a short communication.美国东北部波瓦桑病毒病的激增:一个公共卫生问题——一篇简短通讯
Ann Med Surg (Lond). 2023 Sep 14;85(11):5823-5826. doi: 10.1097/MS9.0000000000001313. eCollection 2023 Nov.
9
Neuroinvasive Flavivirus Pathogenesis Is Restricted by Host Genetic Factors in Collaborative Cross Mice, Independently of .神经侵袭性黄病毒发病机制受协作交叉小鼠宿主遗传因素的限制,与......无关。
J Virol. 2023 Jul 27;97(7):e0071523. doi: 10.1128/jvi.00715-23. Epub 2023 Jun 13.
10
T Cells in Tick-Borne Flavivirus Encephalitis: A Review of Current Paradigms in Protection and Disease Pathology.蜱传黄病毒脑炎中的 T 细胞:保护和疾病发病机制现有范式的综述。
Viruses. 2023 Apr 13;15(4):958. doi: 10.3390/v15040958.
广泛中和性单克隆抗体可抵御多种蜱传黄病毒。
J Exp Med. 2021 May 3;218(5). doi: 10.1084/jem.20210174.
4
A novel synthetic DNA vaccine elicits protective immune responses against Powassan virus.一种新型合成 DNA 疫苗可引发针对波瓦桑病毒的保护性免疫应答。
PLoS Negl Trop Dis. 2020 Oct 29;14(10):e0008788. doi: 10.1371/journal.pntd.0008788. eCollection 2020 Oct.
5
Tick-Borne Encephalitis Virus: A Quest for Better Vaccines against a Virus on the Rise.蜱传脑炎病毒:寻求针对一种日益流行病毒的更好疫苗
Vaccines (Basel). 2020 Aug 12;8(3):451. doi: 10.3390/vaccines8030451.
6
Analysis of Serum Anti-Zika Virus Antibodies by Focus Reduction Neutralization Test.采用焦点减少中和试验分析血清抗寨卡病毒抗体。
Methods Mol Biol. 2020;2142:73-80. doi: 10.1007/978-1-0716-0581-3_6.
7
The continued threat of emerging flaviviruses.新兴黄病毒的持续威胁。
Nat Microbiol. 2020 Jun;5(6):796-812. doi: 10.1038/s41564-020-0714-0. Epub 2020 May 4.
8
Rapid Induction and Maintenance of Virus-Specific CD8 T and CD4 T Cells Following Protective Vaccination Against Dengue Virus Challenge in Humans.在人类接种登革热病毒疫苗以预防病毒感染后,迅速诱导和维持病毒特异性 CD8 T 和 CD4 T 细胞。
Front Immunol. 2020 Mar 24;11:479. doi: 10.3389/fimmu.2020.00479. eCollection 2020.
9
T Cell Responses Induced by Attenuated Flavivirus Vaccination Are Specific and Show Limited Cross-Reactivity with Other Flavivirus Species.减毒黄病毒疫苗诱导的 T 细胞反应具有特异性,与其他黄病毒种属表现出有限的交叉反应性。
J Virol. 2020 May 4;94(10). doi: 10.1128/JVI.00089-20.
10
Beneficial and Detrimental Effects of Regulatory T Cells in Neurotropic Virus Infections.调节性 T 细胞在神经嗜性病毒感染中的有益和有害效应。
Int J Mol Sci. 2020 Mar 2;21(5):1705. doi: 10.3390/ijms21051705.